Cover Image
市場調查報告書

行動醫療的生態系統:市場機會、課題、策略、預測 (2015-2030年)

The mHealth (Mobile Healthcare) Ecosystem: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

出版商 Signals and Systems Telecom 商品編碼 338923
出版日期 內容資訊 英文 161 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
行動醫療的生態系統:市場機會、課題、策略、預測 (2015-2030年) The mHealth (Mobile Healthcare) Ecosystem: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts
出版日期: 2015年09月08日 內容資訊: 英文 161 Pages
簡介

2016年的行動醫療的市場估計達到近180億美元的規模。僅管有法律規章上的課題及患者的接受度、隱私上的疑慮等障礙,在該市場今後5年中預計仍以40%的年複合成長率成長。

本報告提供行動醫療的生態系統相關的總括性調查、行動醫療的發展過程、推動市場成長的要素與阻礙要素、產業發展藍圖與價值鏈、行動醫療的經營模式與案例研究、主要解決方案供應商簡介、各服務區分/地區的收益的變化與預測、給相關經營者的建議等彙整資料。

第1章 簡介

第2章 行動醫療概要

  • 行動醫療是什麼?
  • 從電子醫療到行動醫療的演變
  • 遠程醫療
  • 健康資訊學
  • 行動醫療的商務案例
  • 主要的市場促進因素
  • 成長的障礙
  • 行動醫療技術
    • 智慧型手機 & 平板電腦
    • 行動應用程式
    • 行動應用程式:LTE的時代
    • 穿戴式人體感測器
    • M2M技術
    • 行動視訊通話
  • 行動醫療的利用案例類別
    • 醫藥品
    • 醫療資訊、健康管理
    • 醫療保健&健身
    • 遠隔諮詢、診斷服務
    • M2M、穿戴式技術、感測器、監測應用

第3章 行動醫療的價值鏈和產業藍圖

  • 行動醫療的價值鏈
  • 行動醫療的產業藍圖

第4章 行動醫療的利用案例

  • 醫藥品相關
    • 安全性資料的收集
    • 消費者的教育
    • 醫學教育
    • 市售後監視
    • 醫藥品核准
    • 社群媒體
    • 病人依從性、保持:臨床試驗
  • 醫療資訊、健康管理
    • 電子病歷、追蹤工具
    • 診斷工具、醫療文獻
    • 持續的醫學教育
    • 警報、通知
    • 流通、支付支援
  • 醫療保健&健身
    • 醫學遵守
    • 健身&營養價值應用程式
    • 臨床決策支援系統
    • 處方可能的行動應用程式
  • 遠隔諮詢、診斷服務
    • 行動視訊協商、合作、手術
    • 非視訊協商&合作
    • 緊急的時候的遠隔合作
  • M2M、穿戴式技術、感測器、監測應用
    • 養生保健監測
    • 疾病監視/遠端監控
    • 診斷工具
    • 技術物流

第5章 行動醫療的引進:案例研究

  • Apollo Hospitals Group
  • AT&T
  • London Air Ambulance
  • Novartis
  • Orange Healthcare
  • Praekelt Foundation
  • Qualcomm
  • Roche
  • Verizon
  • WellDoc

第6章 行動醫療解決方案供應商簡介

  • 27Vision
  • 3L Labs
  • 3M
  • 4DForce
  • 4iii Innovations
  • Adidas
  • Aerotel Medical Systems
  • Aetna
  • AGFA Healthcare
  • AirStrip Technologies
  • Alego Health
  • Alivecor
  • AllScripts Healthcare Solutions
  • AMD Global Telemedicine
  • Amiigo
  • Apple
  • Asics
  • AT&T
  • Atlas Wearables
  • AthenaHealth
  • Augmendix
  • BettrLife
  • Bionym
  • Biosensics
  • Boston Scientific
  • Breakthrough Technologies
  • Broadcom
  • BSX Athletics
  • BlackBerry
  • BTS Bioengineering
  • Cambridge Consultants
  • Cambridge Temperature Concepts
  • CardioComm Solutions
  • CardioNet
  • Carre Technologies
  • Catapult
  • CellTrust Corporation
  • Cerner Corporation
  • Chetu
  • Cisco Systems
  • Cityzen Sciences
  • Codoon
  • Cyberdyne
  • DELTA
  • DT (Deutsche Telekom)
  • DocbookMD
  • DorsaVi (ASX)
  • Diversinet Corporation
  • Dreamtrap Commercials
  • EB Sport Group (Sync)
  • E-Clinical Works
  • e-Cycle
  • EdanSafe
  • Ekso Bionics
  • Emotiv Systems
  • Epic Systems Corporation
  • Epion Health
  • Epocrates (Athena Health的一部份)
  • Ericsson
  • European Medical Network (Medical Network EMN AG)
  • Evena Medical
  • EWA Solutions AB
  • Extension Healthcare
  • Fatigue Science
  • Finis
  • Fitbit
  • Flyfit
  • Freescale Semiconductor
  • FRUCT MD
  • Garmin
  • Gemalto
  • GE Healthcare
  • Ginger.io
  • Google
  • GOQii
  • GSK (GlaxoSmithKline)
  • HealBe
  • HealthTechHatch
  • Honeywell Life Care Solutions
  • Hovding
  • HP
  • Huawei
  • i4C Innovations
  • IBM
  • ICEdot
  • Ideal Life
  • iHealth Lab
  • Imec
  • Imprivata
  • Integron Corporation
  • Intel Corporation
  • InteraXon
  • Intermountain Healthcare
  • InTouch Health
  • Instabeat
  • InvenSense
  • IQMax
  • iRhythm
  • Jawbone
  • Jaybird
  • Johnson & Johnson
  • KDDI
  • Ki Performance Lifestyle
  • KORE Telematics
  • Kreyos
  • Lark Technologies
  • Lechal
  • LG Electronics
  • Lumo BodyTech
  • Magellan (MiTAC Digital Corporation)
  • Medecin Direct
  • MedSignals
  • Medtronic
  • MedWeb
  • Melon
  • mHealthAlert
  • McKinsey & Company
  • Microsoft
  • Mio Global
  • Misfit Wearables
  • Moov
  • Moticon
  • Motion Computing
  • Motion Fitness
  • Motorola Mobility / Lenovo
  • Myontec
  • mQure
  • NeuroPro
  • Nike
  • Nonin Medical
  • Notch Interfaces
  • Novartis
  • NTT DoCoMo
  • Nuubo
  • NZN Labs
  • OnLine Tech
  • Omron Corporation
  • OMsignal
  • Optalert
  • Orange
  • Orpyx Medical Technologies
  • O-Synce
  • Owlet Baby Care
  • Panasonic Corporation
  • Pharmica Consulting
  • Philips
  • Phyode
  • Polar Electro
  • Pragmasystems
  • Preventice
  • Proteus Digital Health
  • PUSH Design Solutions
  • Qardio
  • Qualcomm Life
  • Rest Devices
  • Roche Holding (F. Hoffmann-La Roche)
  • RSLSteeper
  • SGroup
  • Samsung
  • Sanofi
  • Santech
  • SAP
  • SCOTTY Group
  • SenseCore
  • Sensible Baby
  • Senso Solutions
  • Sentimoto
  • Seraphim Sense
  • Siemens Healthcare
  • SK Telecom
  • Snaptracs
  • SoftBank Corporation
  • SoftServe
  • Somaxis
  • Sonitus Medical
  • Sony Corporation
  • Sotera Wireless
  • STMicroelectronics
  • Swissmed Mobile
  • Tactio Health Group
  • TCS (TeleCommunication Systems)
  • Telcare
  • Tele2
  • Telecom Italia
  • Telenor
  • TI (Texas Instruments)
  • 東芝
  • Tunstall Healthcare
  • U-blox
  • Validic (Motivation Science)
  • Vancive Medical Technologies
  • Vodafone Group
  • Verizon
  • Vitaphone
  • Voxiva
  • Wearable Intelligence
  • Wellograph
  • WellDoc
  • Withings
  • Xiaomi
  • Zephyr Technology Corporation
  • Zinc Software
  • Zoll Medical Corporation
  • 其他

第7章 標準、法律規章、開發倡議

  • mHealth Alliance
  • GSMA's mHealth Program
  • Global mHealth Initiative
  • MRC (mHealth Regulatory Coalition)
  • WLSA (Wireless-Life Services Alliance)
  • EuMHA (European mHealth Alliance)
  • mHealth Working Group
  • mHIMSS
  • 其他
  • HIPAA和行動醫療的影響

第8章 市場分析、預測

  • 全球行動醫療收益的預測
  • 各詳細部門市場
  • 醫藥品部門:收益的變化與預測
  • 醫療資訊、健康管理部門:收益的變化與預測
  • 醫療保健&健身部門:收益的變化與預測
  • 遠隔諮詢、診斷服務部門:收益的變化與預測
  • M2M、穿戴式技術、感測器、監測應用部門:收益的變化與預測
  • 各生態系統業者市場
  • 各地區的展望
  • 亞太地區:收益的變化與預測
    • 各國
  • 東歐:收益的變化與預測
    • 各國
  • 中南美:收益的變化與預測
    • 各國
  • 中東、非洲:收益的變化與預測
    • 各國
  • 北美:收益的變化與預測
    • 各國
  • 西歐:收益的變化與預測
    • 各國

第9章 總論、策略性建議

圖表

目錄

With more than 7 Billion mobile network subscriptions worldwide, the mobile communications sector is rapidly gaining traction from a diverse range of vertical sectors. Healthcare is no exception to this trend.

As healthcare providers seek to maximize their patient outreach while minimizing costs, many view mobile healthcare (or mHealth) as the solution to improve healthcare cost-efficiency. mHealth refers to the usage of mobile communications technology & devices to enhance access to healthcare information, improve distribution of routine and emergency health services and provide diagnostic services.

Mobile network operators also view mHealth as a lucrative opportunity for the monetization of their mobile connectivity services as a growing proportion of their subscribers adopt healthcare centric wearables. Given that most operators have established themselves as reputable consumer brands, they are also eyeing on opportunities to offer services beyond simple connectivity. Many operators already offer branded or co-branded end-to-end mHealth solutions to their customer bases.

In addition, mHealth offers a multitude to opportunities to the pharmaceutical industry ranging from R&D activities to securing the supply chain and, in the battle against counterfeit drugs.

Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for nearly $18 Billion in 2016 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of 40% over the next 5 years.

The "mHealth (Mobile Healthcare) Ecosystem: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts" report presents an in-depth assessment of the global mHealth market. In addition to covering key market drivers, challenges, future roadmap, value chain analysis, deployment case studies, service/product strategies and strategic recommendations, the report also presents comprehensive forecasts for the mHealth market from 2015 till 2030. The forecasts and historical revenue figures are individually segmented for 5 individual submarkets, 29 use case categories, 5 ecosystem player categories, 6 geographical regions and 34 countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

Topics Covered

The report covers the following topics:

  • The scope and implementation of mHealth across the globe
  • mHealth technology
  • Market drivers and key benefits of mHealth
  • Challenges and inhibitors to the mHealth ecosystem
  • mHealth standardization and regulatory initiatives
  • mHealth opportunities, use cases and applications
  • mHealth deployment case studies
  • Value chain analysis of the mHealth ecosystem and the recognition of key players in each segment of the value chain
  • mHealth industry roadmap: 2015 - 2030
  • Key trends in the mHealth ecosystem; mHealth regulation & security, adoption of cloud based mHealth services, alliances for ecosystem fortification, and the impact of LTE deployments
  • The role of M2M and wearable technology in the mHealth ecosystem
  • Profiles and strategies of over 200 ecosystem players
  • Strategic recommendations for mobile network operators, wireless infrastructure/device OEMs, application developers, healthcare service providers & pharmaceutical companies to capitalize on the mHealth opportunity
  • In-depth analysis for 5 individual submarkets and their associated mHealth application use cases:
    • Pharmaceutical Applications
    • Medical Information & Healthcare Management
    • Healthcare & Fitness
    • Remote Consultation/Diagnostic Services
    • M2M, Wearable Technology, Sensor & Monitoring Applications
  • Historical revenue figures and forecasts till 2030

Forecast Segmentation

Market forecasts and historical revenue figures are provided for each of the following 5 submarkets and their 23 use case categories:

Pharmaceutical Applications

  • Safety Data Collection
  • Consumer Education
  • Medical Education
  • Post-Market Monitoring
  • Drug Authentication
  • Social Media
  • Patient Compliance & Retention: Clinical Trials

Information & Healthcare Management

  • Electronic Health/Medical Records & Tracking Tools
  • Diagnostic Tools & Medical Reference
  • Continuing Medical Education
  • Awareness Through Alerts
  • Logistical & Payment Support

Healthcare & Fitness

  • Medical Compliance
  • Fitness & Nutrition Apps
  • Clinical Decision Support Systems
  • Prescribable Mobile Apps

Remote Consultation/Diagnostic Services

  • Mobile Video Consultations, Collaboration & Surgery
  • Non-Video Consultations & Collaboration
  • Remote Collaboration in Emergency Situations

M2M, Wearable Technology, Sensor & Monitoring Applications

  • Health and Wellness Monitoring
  • Disease Surveillance/Remote Monitoring
  • Diagnostic Tools
  • Technical Logistics

Revenue is also split by ecosystem player:

Ecosystem Player

  • Mobile Network Operators/Connectivity Providers
  • Mobile & mHealth Device OEMs
  • Content & Application Providers
  • Healthcare Service Providers
  • Pharmaceutical Industry

The following regional and country markets are also covered:

Regional Markets

  • Asia Pacific
  • Eastern Europe
  • Latin & Central America
  • Middle East & Africa
  • North America
  • Western Europe

Country Markets

Argentina, Australia, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK, USA

Additional forecasts are provided for the following:

  • Wireless M2M connections for the mHealth vertical
  • mHealth centric wearable device shipments
  • Mobile video calling users
  • Annual throughput of mobile network data traffic
  • Smartphone, feature phone, tablet, desktop PC and notebook shipments
  • Mobile network subscriptions by region
  • Cost saving potential of mHealth by region
  • Big Data & analytics technology investments in the healthcare sector

Key Questions Answered

The report provides answers to the following key questions:

  • What are the key market drivers and challenges for the mHealth ecosystem?
  • What are the key applications of mHealth?
  • How is the mHealth value chain structured and how will it evolve overtime?
  • What opportunities does mHealth offer to mobile network operators, healthcare service providers, pharmaceutical companies and other players in the value chain?
  • What strategies should mobile network operators, wireless infrastructure & device OEMs, healthcare service providers, pharmaceutical companies and application developers adopt to capitalize on the mHealth opportunity?
  • How big is the mHealth market, and how much revenue will it generate in 2020?
  • What will be the installed base of mHealth M2M connections in 2020?
  • How many mHealth centric wearable devices will be shipped in 2020?
  • What particular submarkets does the mHealth ecosystem constitute?
  • What geographical regions, countries and submarkets offer the greatest growth potential for mHealth?
  • Who are the key players in the mHealth market?
  • What level of cost savings can mHealth facilitate for healthcare service providers in each region?
  • What are the key applications of LTE in the mHealth market?
  • What considerations should be taken into account to devise a successful mHealth strategy for a hospital?

Key Findings

The report has the following key findings:

  • Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for over $18 Billion in 2016 alone
  • Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of 40% over the next 5 years
  • SNS Research estimates that mHealth centric wearable devices will account for over 130 Million unit shipments by the end of 2020. In order to gain valuable insights from the data generated by these devices, healthcare providers and other stakeholders are increasingly investing in Big Data and analytics technology
  • SNS Research estimates that Big Data and analytics technology investments in the healthcare sector will account for over $4 Billion by 2020, following a CAGR of over 14% between 2015 and 2020
  • In a bid to reduce error rates and enhance patient monitoring, pharmaceutical companies are increasingly incorporating smartphone and tablet based monitoring apps in their clinical trials
  • mHealth has the potential to dramatically reduce the costs of healthcare operations, while improving the quality of healthcare. SNS Research estimates that by the end of 2016, mHealth could represent up to $340 Billion in annual healthcare cost savings worldwide

Table of Contents

1 Chapter 1: Introduction

  • 1.1 Executive Summary
  • 1.2 Topics Covered
  • 1.3 Forecast Segmentation
  • 1.4 Key Questions Answered
  • 1.5 Key Findings
  • 1.6 Methodology
  • 1.7 Target Audience
  • 1.8 Companies & Organizations Mentioned

2 Chapter 2: An Overview of mHealth

  • 2.1 What is mHealth?
  • 2.2 The Evolution from eHealth to mHealth
  • 2.3 Telemedicine
  • 2.4 Health Informatics
  • 2.5 The mHealth Business Case
  • 2.6 Key Market Drivers
    • 2.6.1 Increasing Penetration of Smartphones, Tablets & Wearables
    • 2.6.2 Proliferation of Mobile Broadband Networks
    • 2.6.3 The Rise of Chronic Diseases
    • 2.6.4 Growing mHealth Applications: Reduction in Lead Time
    • 2.6.5 Government & Regulatory Initiatives
    • 2.6.6 Physicians at Forefront of Mobility Adoption
    • 2.6.7 The Cost Saving Potential of mHealth
    • 2.6.8 Increasing Adoption of Open Source Software
    • 2.6.9 The Role of Developed Economies
    • 2.6.10 The Role of Emerging Economies
  • 2.7 Barriers to Growth
    • 2.7.1 Security/Privacy Concerns & Absence of Legal Guidelines
    • 2.7.2 Regulation & Efficacy of Applications
    • 2.7.3 Operational Maintenance & Control
    • 2.7.4 Human Behavior: Disbelief among Patients
    • 2.7.5 Lack of Clear mHealth Strategies
    • 2.7.6 Funding Challenges
  • 2.8 mHealth Technologies
    • 2.8.1 Smartphones & Tablets
    • 2.8.2 Mobile Apps
    • 2.8.3 Mobile Broadband: The LTE Era
    • 2.8.4 Wearable Body Sensors
    • 2.8.5 M2M Technology
    • 2.8.6 Mobile Video Calling
  • 2.9 mHealth Use Case Categories
    • 2.9.1 Pharmaceutical Applications
    • 2.9.2 Medical Information & Healthcare Management
    • 2.9.3 Healthcare & Fitness
    • 2.9.4 Remote Consultation/Diagnostic Services
    • 2.9.5 M2M, Wearable Technology, Sensor & Monitoring Applications

3 Chapter 3: mHealth Value Chain and Industry Roadmap

  • 3.1 The mHealth Value Chain
    • 3.1.1 Mobile/mHealth Device, Chipset & Infrastructure OEMs
    • 3.1.2 Mobile Network Operators
    • 3.1.3 Healthcare Professionals & Providers
    • 3.1.4 Insurers and Government Health Systems
    • 3.1.5 The Pharmaceutical Industry
    • 3.1.6 Application Developers & Integrators
    • 3.1.7 Patients
  • 3.2 The mHealth Industry Roadmap: 2015 - 2030
    • 3.2.1 2015 - 2020: Commercialization of Consumer Centric mHealth Apps & Devices
    • 3.2.2 2020 - 2025: Large Scale Proliferation of Remote Video Consultations & Advanced Apps
    • 3.2.3 2025 - 2030: The Era of mHealth Analytics

4 Chapter 4: mHealth Use Cases

  • 4.1 Pharmaceutical Applications
    • 4.1.1 Safety Data Collection
    • 4.1.2 Consumer Education
    • 4.1.3 Medical Education
    • 4.1.4 Post-Market Monitoring
    • 4.1.5 Drug Authentication
    • 4.1.6 Social Media
    • 4.1.7 Patient Compliance & Retention: Clinical Trials
  • 4.2 Medical Information & Healthcare Management
    • 4.2.1 Electronic Health/Medical Records & Tracking Tools
    • 4.2.2 Diagnostic Tools & Medical Reference
    • 4.2.3 Continuing Medical Education
    • 4.2.4 Awareness through Alerts
    • 4.2.5 Logistical & Payment Support
  • 4.3 Healthcare & Fitness
    • 4.3.1 Medical Compliance
    • 4.3.2 Fitness & Nutrition Apps
    • 4.3.3 Clinical Decision Support Systems
    • 4.3.4 Prescribable Mobile Apps
  • 4.4 Remote Consultation/Diagnostics Services
    • 4.4.1 Mobile Video Consultations, Collaboration & Surgery
    • 4.4.2 Non-Video Consultations & Collaboration
    • 4.4.3 Remote Collaboration in Emergency Situations
  • 4.5 M2M, Wearable Technology, Sensor & Monitoring Applications
    • 4.5.1 Health & Wellness Monitoring
    • 4.5.2 Disease Surveillance/Remote Monitoring
    • 4.5.3 Diagnostic Tools
    • 4.5.4 Technical Logistics

5 Chapter 5: mHealth Deployment Case Studies

  • 5.1 Apollo Hospitals Group: Enabling mHealth for the Masses
  • 5.2 AT&T: Connected Healthcare Monitoring for the Elderly
  • 5.3 London Air Ambulance: Utilizing EE's 4G LTE Network to Power Navigation
  • 5.4 Novartis: Clinical Trials of the Future
  • 5.5 Orange Healthcare: Fighting Counterfeit Drugs using SMS Technology
  • 5.6 Praekelt Foundation: HIV/AIDS Awareness Campaign
  • 5.7 Qualcomm: 3G-Enabled Kit for Monitoring Asthmatic Children
  • 5.8 Roche: Powering Clinical Trials with Smartphones
  • 5.9 Verizon: Cloud Based Healthcare Management
  • 5.10 WellDoc: Managing Chronic Diseases using Mobile Apps

6 Chapter 6: mHealth Solution Provider Profiles

  • 6.1 270 Vision
  • 6.2 3L Labs
  • 6.3 3M
  • 6.4 4DForce
  • 6.5 4iii Innovations
  • 6.6 Adidas
  • 6.7 Aerotel Medical Systems
  • 6.8 Aetna
  • 6.9 AGFA Healthcare
  • 6.10 AirStrip Technologies
  • 6.11 Alego Health
  • 6.12 Alivecor
  • 6.13 AllScripts Healthcare Solutions
  • 6.14 AMD Global Telemedicine
  • 6.15 Amiigo
  • 6.16 Apple
  • 6.17 Asics
  • 6.18 AT&T
  • 6.19 Atlas Wearables
  • 6.20 AthenaHealth
  • 6.21 Augmendix
  • 6.22 BettrLife
  • 6.23 Bionym
  • 6.24 Biosensics
  • 6.25 Boston Scientific
  • 6.26 Breakthrough Technologies
  • 6.27 Broadcom
  • 6.28 BSX Athletics
  • 6.29 BlackBerry
  • 6.30 BTS Bioengineering
  • 6.31 Cambridge Consultants
  • 6.32 Cambridge Temperature Concepts
  • 6.33 CardioComm Solutions
  • 6.34 CardioNet
  • 6.35 Carre Technologies
  • 6.36 Catapult
  • 6.37 CellTrust Corporation
  • 6.38 Cerner Corporation
  • 6.39 Chetu
  • 6.40 Cisco Systems
  • 6.41 Cityzen Sciences
  • 6.42 Codoon
  • 6.43 Cyberdyne
  • 6.44 DELTA
  • 6.45 DT (Deutsche Telekom)
  • 6.46 DocbookMD
  • 6.47 DorsaVi (ASX)
  • 6.48 Diversinet Corporation
  • 6.49 Dreamtrap Commercials
  • 6.50 EB Sport Group (Sync)
  • 6.51 E-Clinical Works
  • 6.52 e-Cycle
  • 6.53 EdanSafe
  • 6.54 Ekso Bionics
  • 6.55 Emotiv Systems
  • 6.56 Epic Systems Corporation
  • 6.57 Epion Health
  • 6.58 Epocrates (Part of Athena Health)
  • 6.59 Ericsson
  • 6.60 European Medical Network (Medical Network EMN AG)
  • 6.61 Evena Medical
  • 6.62 EWA Solutions AB
  • 6.63 Extension Healthcare
  • 6.64 Fatigue Science
  • 6.65 Finis
  • 6.66 Fitbit
  • 6.67 Flyfit
  • 6.68 Freescale Semiconductor
  • 6.69 FRUCT MD
  • 6.70 Garmin
  • 6.71 Gemalto
  • 6.72 GE Healthcare
  • 6.73 Ginger.io
  • 6.74 Google
  • 6.75 GOQii
  • 6.76 GSK (GlaxoSmithKline)
  • 6.77 HealBe
  • 6.78 HealthTechHatch
  • 6.79 Honeywell Life Care Solutions
  • 6.80 Hovding
  • 6.81 HP
  • 6.82 Huawei
  • 6.83 i4C Innovations
  • 6.84 IBM
  • 6.85 ICEdot
  • 6.86 Ideal Life
  • 6.87 iHealth Lab
  • 6.88 Imec
  • 6.89 Imprivata
  • 6.90 Integron Corporation
  • 6.91 Intel Corporation
  • 6.92 InteraXon
  • 6.93 Intermountain Healthcare
  • 6.94 InTouch Health
  • 6.95 Instabeat
  • 6.96 InvenSense
  • 6.97 IQMax
  • 6.98 iRhythm
  • 6.99 Jawbone
  • 6.100 Jaybird
  • 6.101 Johnson & Johnson
  • 6.102 KDDI Corporation
  • 6.103 Ki Performance Lifestyle
  • 6.104 KORE Telematics
  • 6.105 Kreyos
  • 6.106 Lark Technologies
  • 6.107 Lechal
  • 6.108 LG Electronics
  • 6.109 Lumo BodyTech
  • 6.110 Magellan (MiTAC Digital Corporation)
  • 6.111 Medecin Direct
  • 6.112 MedSignals
  • 6.113 Medtronic
  • 6.114 MedWeb
  • 6.115 Melon
  • 6.116 mHealthAlert
  • 6.117 McKinsey & Company
  • 6.118 Microsoft
  • 6.119 Mio Global
  • 6.120 Misfit Wearables
  • 6.121 Moov
  • 6.122 Moticon
  • 6.123 Motion Computing
  • 6.124 Motion Fitness
  • 6.125 Motorola Mobility / Lenovo
  • 6.126 Myontec
  • 6.127 mQure
  • 6.128 NeuroPro
  • 6.129 Nike
  • 6.130 Nonin Medical
  • 6.131 Notch Interfaces
  • 6.132 Novartis
  • 6.133 NTT DoCoMo
  • 6.134 Nuubo
  • 6.135 NZN Labs
  • 6.136 OnLine Tech
  • 6.137 Omron Corporation
  • 6.138 OMsignal
  • 6.139 Optalert
  • 6.140 Orange
  • 6.141 Orpyx Medical Technologies
  • 6.142 O-Synce
  • 6.143 Owlet Baby Care
  • 6.144 Panasonic Corporation
  • 6.145 Pharmica Consulting
  • 6.146 Philips
  • 6.147 Phyode
  • 6.148 Polar Electro
  • 6.149 Pragmasystems
  • 6.150 Preventice
  • 6.151 Proteus Digital Health
  • 6.152 PUSH Design Solutions
  • 6.153 Qardio
  • 6.154 Qualcomm Life
  • 6.155 Rest Devices
  • 6.156 Roche Holding (F. Hoffmann-La Roche)
  • 6.157 RSLSteeper
  • 6.158 S3 Group
  • 6.159 Samsung
  • 6.160 Sanofi
  • 6.161 Santech
  • 6.162 SAP
  • 6.163 SCOTTY Group
  • 6.164 SenseCore
  • 6.165 Sensible Baby
  • 6.166 Senso Solutions
  • 6.167 Sentimoto
  • 6.168 Seraphim Sense
  • 6.169 Siemens Healthcare
  • 6.170 SK Telecom
  • 6.171 Snaptracs
  • 6.172 SoftBank Corporation
  • 6.173 SoftServe
  • 6.174 Somaxis
  • 6.175 Sonitus Medical
  • 6.176 Sony Corporation
  • 6.177 Sotera Wireless
  • 6.178 STMicroelectronics
  • 6.179 Swissmed Mobile
  • 6.180 Tactio Health Group
  • 6.181 TCS (TeleCommunication Systems)
  • 6.182 Telcare
  • 6.183 Tele2
  • 6.184 Telecom Italia
  • 6.185 Telenor
  • 6.186 TI (Texas Instruments)
  • 6.187 Toshiba Corporation
  • 6.188 Tunstall Healthcare
  • 6.189 U-blox
  • 6.190 Validic (Motivation Science)
  • 6.191 Vancive Medical Technologies
  • 6.192 Vodafone Group
  • 6.193 Verizon
  • 6.194 Vitaphone
  • 6.195 Voxiva
  • 6.196 Wearable Intelligence
  • 6.197 Wellograph
  • 6.198 WellDoc
  • 6.199 Withings
  • 6.200 Xiaomi
  • 6.201 Zephyr Technology Corporation
  • 6.202 Zinc Software
  • 6.203 Zoll Medical Corporation
  • 6.204 Others

7 Chapter 7: Standardization, Regulation & Development Initiatives

  • 7.1 mHealth Alliance
  • 7.2 GSMA's mHealth Program
  • 7.3 Global mHealth Initiative
  • 7.4 MRC (mHealth Regulatory Coalition)
  • 7.5 WLSA (Wireless-Life Services Alliance)
  • 7.6 EuMHA (European mHealth Alliance)
  • 7.7 mHealth Working Group
  • 7.8 mHIMSS
  • 7.9 Others
  • 7.10 HIPAA and its Implications on mHealth

8 Chapter 8: Market Analysis & Forecasts

  • 8.1 Global Outlook of mHealth Revenue: 2015 - 2030
  • 8.2 Submarket Segmentation
  • 8.3 Pharmaceutical Applications Submarket Revenue: 2015 - 2030
    • 8.3.1 Safety Data Collection Use Case
    • 8.3.2 Consumer Education Use Case
    • 8.3.3 Medical Education Use Case
    • 8.3.4 Post-Market Monitoring Use Case
    • 8.3.5 Drug Authentication Use Case
    • 8.3.6 Social Media Use Case
    • 8.3.7 Patient Compliance & Retention (Clinical Trials) Use Case
  • 8.4 Medical Information & Healthcare Management Submarket Revenue: 2015 - 2030
    • 8.4.1 Electronic Health/Medical Records & Tracking Tools Use Case
    • 8.4.2 Diagnostic Tools & Medical Reference Use Case
    • 8.4.3 Continuing Medical Education Use Case
    • 8.4.4 Awareness through Alerts Use Case
    • 8.4.5 Logistical & Payment Support Use Case
  • 8.5 Healthcare & Fitness Submarket Revenue: 2015 - 2030
    • 8.5.1 Medical Compliance Use Case
    • 8.5.2 Fitness & Nutrition Apps Use Case
    • 8.5.3 Clinical Decision Support Systems Use Case
    • 8.5.4 Prescribable Mobile Apps Use Case
  • 8.6 Remote Consultation/Diagnostic Services Submarket Revenue: 2015 - 2030
    • 8.6.1 Mobile Video Consultations, Collaboration & Surgery Use Case
    • 8.6.2 Non-Video Consultations & Collaboration Use Case
    • 8.6.3 Remote Collaboration in Emergency Situations Use Case
  • 8.7 M2M, Wearable Technology, Sensor & Monitoring Applications Submarket Revenue: 2015 - 2030
    • 8.7.1 Health and Wellness Monitoring Use Case
    • 8.7.2 Disease Surveillance/Remote Monitoring Use Case
    • 8.7.3 Diagnostic Tools Use Case
    • 8.7.4 Technical Logistics Use Case
  • 8.8 Segmentation by Ecosystem Player
    • 8.8.1 Mobile Network Operators/Connectivity Providers
    • 8.8.2 Mobile & mHealth Device OEMs
    • 8.8.3 Content & Application Providers
    • 8.8.4 Healthcare Service Providers
    • 8.8.5 Pharmaceutical Industry
  • 8.9 Regional Outlook
  • 8.10 Asia Pacific mHealth Revenue: 2015 - 2030
    • 8.10.1 Country Level Segmentation
    • 8.10.2 Australia
    • 8.10.3 China
    • 8.10.4 India
    • 8.10.5 Japan
    • 8.10.6 South Korea
    • 8.10.7 Pakistan
    • 8.10.8 Thailand
    • 8.10.9 Indonesia
    • 8.10.10 Malaysia
    • 8.10.11 Taiwan
    • 8.10.12 Philippines
    • 8.10.13 Singapore
    • 8.10.14 Rest of Asia Pacific
  • 8.11 Eastern Europe mHealth Revenue: 2015 - 2030
    • 8.11.1 Country Level Segmentation
    • 8.11.2 Czech Republic
    • 8.11.3 Poland
    • 8.11.4 Russia
    • 8.11.5 Rest of Eastern Europe
  • 8.12 Latin & Central America mHealth Revenue: 2015 - 2030
    • 8.12.1 Country Level Segmentation
    • 8.12.2 Argentina
    • 8.12.3 Brazil
    • 8.12.4 Mexico
    • 8.12.5 Rest of Latin & Central America
  • 8.13 Middle East & Africa mHealth Revenue: 2015 - 2030
    • 8.13.1 Country Level Segmentation
    • 8.13.2 Israel
    • 8.13.3 Qatar
    • 8.13.4 Saudi Arabia
    • 8.13.5 South Africa
    • 8.13.6 UAE
    • 8.13.7 Rest of the Middle East & Africa
  • 8.14 North America mHealth Revenue: 2015 - 2030
    • 8.14.1 Country Level Segmentation
    • 8.14.2 USA
    • 8.14.3 Canada
  • 8.15 Western Europe mHealth Revenue: 2015 - 2030
    • 8.15.1 Country Level Segmentation
    • 8.15.2 Denmark
    • 8.15.3 Finland
    • 8.15.4 France
    • 8.15.5 Germany
    • 8.15.6 Italy
    • 8.15.7 Spain
    • 8.15.8 Sweden
    • 8.15.9 Norway
    • 8.15.10 UK
    • 8.15.11 Rest of Western Europe

9 Chapter 9: Conclusion & Strategic Recommendations

  • 9.1 Are Prescribable Mobile Apps a Threat to the Pharmaceutical Industry?
  • 9.2 Will mHealth Requirements Drive HD Mobile Video Deployments?
  • 9.3 Is mHealth Security an All-or-nothing Decision?
  • 9.4 Healthcare Industry Approval & Accreditation: Key to Success
  • 9.5 Maintenance of Low Costs
  • 9.6 Increase of Operational Efficiency
  • 9.7 Collaborations Help in Promoting mHealth
  • 9.8 The Importance of End User Belief
  • 9.9 Wearable Technology: Prospects in the mHealth Ecosystem
  • 9.1 Are Mobile Network Operators Simply Connectivity Providers for mHealth?
  • 9.11 Driving Investments in Big Data & Analytics
  • 9.12 Implementing Successful mHealth Strategies in Hospitals
  • 9.13 Strategic Recommendations
    • 9.13.1 Recommendations for Mobile Network Operators
    • 9.13.2 Recommendations for Wireless Infrastructure & Device OEMs
    • 9.13.3 Recommendations for Application Developers
    • 9.13.4 Recommendations for Healthcare Professionals and Providers
    • 9.13.5 Recommendations for the Pharmaceutical Industry

List of Figures

  • Figure 1: Global Connected Consumer Mobile Device vs. PC Shipments: 2015 - 2030 (Millions of Units)
  • Figure 2: Mobile Network Subscriptions by Region: 2015 - 2030 (Millions)
  • Figure 3: Annual Global Throughput of Mobile Network Data Traffic by Region: 2015 - 2030 (Exabytes)
  • Figure 4: Cost Saving Potential of mHealth by Region: 2015 - 2030 ($ Million)
  • Figure 5: M2M Architecture
  • Figure 6: Global Wireless M2M Connections for mHealth Applications: 2015 - 2030 (Millions)
  • Figure 7: Global Mobile Video Calling Users: 2015 - 2030 (Millions)
  • Figure 8: mHealth Use Case Categories
  • Figure 9: The mHealth Value Chain
  • Figure 10: mHealth Industry Roadmap: 2015 - 2030
  • Figure 11: Global mHealth Revenue: 2015 - 2030 ($ Million)
  • Figure 12: Global mHealth Revenue by Submarket: 2015 - 2030 ($ Million)
  • Figure 13: Global Pharmaceutical Applications Submarket Revenue: 2015 - 2030 ($ Million)
  • Figure 14: Global Pharmaceutical Applications Submarket Revenue by Use Case Category: 2015 - 2030 ($ Million)
  • Figure 15: Global Safety Data Collection Use Case Revenue: 2015 - 2030 ($ Million)
  • Figure 16: Global Consumer Education Use Case Revenue: 2015 - 2030 ($ Million)
  • Figure 17: Global Medical Education Use Case Revenue: 2015 - 2030 ($ Million)
  • Figure 18: Global Post-Market Monitoring Use Case Revenue: 2015 - 2030 ($ Million)
  • Figure 19: Global Drug Authentication Use Case Revenue: 2015 - 2030 ($ Million)
Back to Top